Helmsley Charitable Trust Grants $4.7m to Fund Life-Saving Technology to Confront Cardiac Threat from COVID-19

Helmsley Charitable Trust reports $4,711,481 in funding will be distributed across five upper-midwestern states to pay for 367 LUCAS mechanical CPR devices to be deployed to hospitals caring for patients during the pandemic and beyond.

“These devices are vital because we don’t want frontline healthcare workers to choose between trying to save a patient or risking exposure to themselves and others to the Coronavirus,” said Walter Panzirer, a trustee for the Helmsley Charitable Trust. “LUCAS has been a proven, effective tool in saving lives during cardiac arrest, and having more of them available during this pandemic will save even more lives, including those of the doctors, nurses and other healthcare workers.”

Research has shown cardiac damage in as many as 1 in 5 COVID-19 patients, leading to heart failure and death even among those who show no signs of respiratory distress. Among patients who recover, many could have long-term effects from such heart damage.

The rise in cardiac complications caused by COVID-19 exposes both patients and healthcare workers to greater risk, as hands-on CPR can be needed for extended periods. Mechanical CPR has been adopted by emergency medical responders and many hospitals around the globe.

The Helmsley Charitable Trust is partnering with medical facilities in South Dakota, North Dakota, Montana, Wyoming, and Nebraska to ensure the devices are in place before the peak of COVID-19 hits. The devices will remain in place after the pandemic as part of the hospitals’ cardiac system of care.

“We were able to go from concept to delivery of the devices in two weeks, and that’s been an incredible effort of teamwork with the manufacturer and the hospitals,” said Panzirer.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.